Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells (original) (raw)
Powell EE, Cooksley WG, Hanson R, Searle J, et al. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990, 11:74–80. ArticlePubMed Google Scholar
Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, et al. Clinical characterization and risk factors for underlying disease. Hepatology 1999, 29:664–669. ArticleCASPubMed Google Scholar
Ratziu V, Bonyhay L, Di MV, Charlotte F, et al. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology 2002, 35:1485–1493. ArticlePubMed Google Scholar
Day CP, James OF . Steatohepatitis. a tale of two “hits”?. Gastroenterology 1998, 114:842–845. ArticleCASPubMed Google Scholar
Teli MR, James OF, Burt AD, Bennett MK, Day CP . The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 1995, 22:1714–1719. ArticleCASPubMed Google Scholar
Nehra V, Angulo P, Buchman AL, Lindor KD . Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis. Dig Dis Sci 2001, 46:2347–2352. ArticleCASPubMed Google Scholar
Seki S, Kitada T, Yamada T, Sakaguchi H, et al. In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J Hepatol 2002, 37:56–62. ArticleCASPubMed Google Scholar
Caldwell SH, Swerdlow RH, Khan EM, Iezzoni JC, et al. Mitochondrial abnormalities in non-alcoholic steatohepatitis. J Hepatol 1999, 31:430–434. ArticleCASPubMed Google Scholar
Perez-Carreras M, Del Hoyo P, Martin MA, Rubio JC, et al. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 2003, 38:999–1007. ArticleCASPubMed Google Scholar
Reeves HL, Burt AD, Wood S, Day CP . Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis. J Hepatol 1996, 25:677–683. ArticleCASPubMed Google Scholar
Wahren J, Sato Y, Ostman J, Hagenfeldt L, Felig P . Turnover and splanchnic metabolism of free fatty acids and ketones in insulin-dependent diabetics at rest and in response to exercise. J Clin Invest 1984, 73:1367–1376. ArticleCASPubMedPubMed Central Google Scholar
Friedman SL . Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications. Nat Clin Pract Gastroenterol Hepatol 2004, 1:98–105. ArticlePubMed Google Scholar
Tavill AS . Intracellular pathways of protein synthesis and secretion in the hepatocyte. Semin Liver Dis 1985, 5:95–109. ArticleCASPubMed Google Scholar
Kleinfeld AM, Prothro D, Brown DL, Davis RC, et al. Increases in serum unbound free fatty acid levels following coronary angioplasty. Am J Cardiol 1996, 78:1350–1354. ArticleCASPubMed Google Scholar
Novo E, Marra F, Zamara E . Valfre dB, et al. Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans. Gut 2006, 55:1174–1182. ArticleCASPubMedPubMed Central Google Scholar
Schnabl B, Choi YH, Olsen JC, Hagedorn CH, Brenner DA . Immortal activated human hepatic stellate cells generated by ectopic telomerase expression. Lab Invest 2002, 82:323–333. ArticleCASPubMed Google Scholar
Schnabl B, Purbeck CA, Choi YH, Hagedorn CH, Brenner D . Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype. Hepatology 2003, 37:653–664. ArticleCASPubMed Google Scholar
Hickman IJ, Clouston AD, Macdonald GA, Purdie DM, et al. Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C. Gut 2002, 51:89–94. ArticleCASPubMedPubMed Central Google Scholar
Rockey DC, Boyles JK, Gabbiani G, Friedman SL . Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J Submicrosc Cytol Pathol 1992, 24:193–203. CASPubMed Google Scholar
Ueberham E, Low R, Ueberham U, Schonig K, et al. Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis. Hepatology 2003, 37:1067–1078. ArticleCASPubMed Google Scholar
Qi Z, Atsuchi N, Ooshima A, Takeshita A, Ueno H . Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat. Proc Natl Acad Sci U S A 1999, 96:2345–2349. ArticleCASPubMedPubMed Central Google Scholar
Hellerbrand C, Stefanovic B, Giordano F, Burchardt ER, Brenner DA . The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo. J Hepatol 1999, 30:77–87. ArticleCASPubMed Google Scholar
Schnabl B, Purbeck CA, Choi YH, Hagedorn CH, Brenner D . Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype. Hepatology 2003, 37:653–664. ArticleCASPubMed Google Scholar
Reif S, Lang A, Lindquist JN, Yata Y, et al. The role of focal adhesion kinase-phosphatidylinositol 3-kinase-akt signaling in hepatic stellate cell proliferation and type I collagen expression. J Biol Chem 2003, 278:8083–8090. ArticleCASPubMed Google Scholar
Murphy FR, Issa R, Zhou X, Ratnarajah S, et al. Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis. J Biol Chem 2002, 277:11069–11076. ArticleCASPubMed Google Scholar
Saile B, Matthes N, Knittel T, Ramadori G . Transforming growth factor beta and tumor necrosis factor alpha inhibit both apoptosis and proliferation of activated rat hepatic stellate cells. Hepatology 1999, 30:196–202. ArticleCASPubMed Google Scholar
Issa R, Williams E, Trim N, Kendall T, et al. Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors. Gut 2001, 48:548–557. ArticleCASPubMedPubMed Central Google Scholar
Reif S, Lang A, Lindquist JN, Yata Y, et al. The role of focal adhesion kinase-phosphatidylinositol 3-kinase-akt signaling in hepatic stellate cell proliferation and type I collagen expression. J Biol Chem 2003, 278:8083–8090. ArticleCASPubMed Google Scholar
Hellerbrand C, Jobin C, Licato LL, Sartor RB, Brenner DA . Cytokines induce NF-kappaB in activated but not in quiescent rat hepatic stellate cells. Am J Physiol 1998, 275:G269–G278. CASPubMed Google Scholar
Hellerbrand C, Jobin C, Iimuro Y, Licato L, et al. Inhibition of NFkappaB in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB super-repressor. Hepatology 1998, 27:1285–1295. ArticleCASPubMed Google Scholar
Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, et al. Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology 2001, 34:745–750. ArticleCASPubMed Google Scholar
Yokohama S, Yoneda M, Haneda M, Okamoto S, et al. Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis. Hepatology 2004, 40:1222–1225. ArticleCASPubMed Google Scholar
Hirose A, Ono M, Saibara T, Nozaki Y, et al. Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis. Hepatology 2007, 45:1375–1381. ArticleCASPubMed Google Scholar
Lutchman G, Modi A, Kleiner DE, Promrat K, et al. The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis. Hepatology 2007, 46:424–429. ArticleCASPubMed Google Scholar
Abergel A, Sapin V, Dif N, Chassard C, et al. Growth arrest and decrease of alpha-SMA and type I collagen expression by palmitic acid in the rat hepatic stellate cell line PAV-1. Dig Dis Sci 2006, 51:986–995. ArticleCASPubMed Google Scholar
Kugelmas M, Hill DB, Vivian B, Marsano L, McClain CJ . Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. Hepatology 2003, 38:413–419. ArticleCASPubMed Google Scholar
Schulze-Krebs A, Preimel D, Popov Y, Bartenschlager R, et al. Hepatitis C virus-replicating hepatocytes induce fibrogenic activation of hepatic stellate cells. Gastroenterology 2005, 129:246–258. ArticleCASPubMed Google Scholar
Muhlbauer M, Bosserhoff AK, Hartmann A, Thasler WE, et al. A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease. Gastroenterology 2003, 125:1085–1093. ArticlePubMed Google Scholar
Hellerbrand C, Amann T, Schlegel J, Wild P, et al. The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma. Gut 2008, 57:243–251. ArticleCASPubMed Google Scholar
Hellerbrand C, Bumes E, Bataille F, Dietmaier W, et al. Reduced expression of CYLD in human colon and hepatocellular carcinomas. Carcinogenesis 2007, 28:21–27. ArticleCASPubMed Google Scholar
Muhlbauer M, Fleck M, Schutz C, Weiss T, et al. PD-L1 is induced in hepatocytes by viral infection and by interferon-alpha and -gamma and mediates T cell apoptosis. J Hepatol 2006, 45:520–528. ArticlePubMed Google Scholar
Cousin SP, Hugl SR, Wrede CE, Kajio H, et al. Free fatty acid-induced inhibition of glucose and insulin-like growth factor I-induced deoxyribonucleic acid synthesis in the pancreatic beta-cell line INS-1. Endocrinology 2001, 142:229–240. ArticleCASPubMed Google Scholar
Buettner R, Newgard CB, Rhodes CJ, O'Doherty RM . Correction of diet-induced hyperglycemia, hyperinsulinemia, and skeletal muscle insulin resistance by moderate hyperleptinemia. Am J Physiol Endocrinol Metab 2000, 278:E563–E569. ArticleCASPubMed Google Scholar
Muhlbauer M, Allard B, Bosserhoff AK, Kiessling S, et al. Differential effects of deoxycholic acid and taurodeoxycholic acid on NF-kappa B signal transduction and IL-8 gene expression in colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol 2004, 286:G1000–G1008. ArticleCASPubMed Google Scholar